Macular Degeneration Treatment Market Report by Type (Dry Age-related Macular Degeneration, Wet Age-related Macular Degeneration), Stage of Disease (Early Stage, Intermediate Stage, Late Stage), Route of Administration (Intravenous Route, Intravitreal Route), End User (Hospitals, Ambulatory Surgical Center, and Others), and Region 2024-2032

Macular Degeneration Treatment Market Report by Type (Dry Age-related Macular Degeneration, Wet Age-related Macular Degeneration), Stage of Disease (Early Stage, Intermediate Stage, Late Stage), Route of Administration (Intravenous Route, Intravitreal Route), End User (Hospitals, Ambulatory Surgical Center, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A5118
Buy Now

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Macular Degeneration Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Type
    6.1    Dry Age-related Macular Degeneration
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Wet Age-related Macular Degeneration
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Stage of Disease
    7.1    Early Stage 
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Intermediate Stage 
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Late Stage 
        7.3.1 Market Trends
        7.3.2 Market Forecast
8   Market Breakup by Route of Administration
    8.1    Intravenous Route
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Intravitreal Route
        8.2.1 Market Trends
        8.2.2 Market Forecast
9   Market Breakup by End User
    9.1    Hospitals
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Ambulatory Surgical Center
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Aerie Pharmaceuticals Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
        15.3.2    Bausch Health Companies Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Bayer AG
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    F. Hoffmann-La Roche Ltd
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
        15.3.5    Iveric Bio Inc.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
        15.3.6    Novartis AG
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Panoptica
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
        15.3.8    Pfizer Inc.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Phio Pharmaceuticals
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
        15.3.10    Regeneron Pharmaceuticals Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Regenxbio Inc.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis
        15.3.12    Santen Pharmaceutical Co. Ltd.
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Macular Degeneration Treatment Market: Major Drivers and Challenges
Figure 2: Global: Macular Degeneration Treatment Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Macular Degeneration Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Macular Degeneration Treatment Market: Breakup by Type (in %), 2023
Figure 5: Global: Macular Degeneration Treatment Market: Breakup by Stage of Disease (in %), 2023
Figure 6: Global: Macular Degeneration Treatment Market: Breakup by Route of Administration (in %), 2023
Figure 7: Global: Macular Degeneration Treatment Market: Breakup by End User (in %), 2023
Figure 8: Global: Macular Degeneration Treatment Market: Breakup by Region (in %), 2023
Figure 9: Global: Macular Degeneration Treatment (Dry Age-related Macular Degeneration) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Macular Degeneration Treatment (Dry Age-related Macular Degeneration) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Macular Degeneration Treatment (Wet Age-related Macular Degeneration) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Macular Degeneration Treatment (Wet Age-related Macular Degeneration) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Macular Degeneration Treatment (Early Stage) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Macular Degeneration Treatment (Early Stage) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Macular Degeneration Treatment (Intermediate Stage) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Macular Degeneration Treatment (Intermediate Stage) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Macular Degeneration Treatment (Late Stage) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Macular Degeneration Treatment (Late Stage) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Macular Degeneration Treatment (Intravenous Route) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Macular Degeneration Treatment (Intravenous Route) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Macular Degeneration Treatment (Intravitreal Route) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Macular Degeneration Treatment (Intravitreal Route) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Macular Degeneration Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Macular Degeneration Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Macular Degeneration Treatment (Ambulatory Surgical Center) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Macular Degeneration Treatment (Ambulatory Surgical Center) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Macular Degeneration Treatment (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Macular Degeneration Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: North America: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: North America: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: United States: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: United States: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Canada: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Canada: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Asia-Pacific: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Asia-Pacific: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: China: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: China: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Japan: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Japan: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: India: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: India: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: South Korea: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: South Korea: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Australia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Australia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Indonesia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Indonesia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Europe: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Europe: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Germany: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Germany: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: France: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: France: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: United Kingdom: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: United Kingdom: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Italy: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Italy: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Spain: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Spain: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Russia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Russia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Latin America: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Latin America: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Brazil: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Brazil: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Mexico: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Mexico: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Middle East and Africa: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Middle East and Africa: Macular Degeneration Treatment Market: Breakup by Country (in %), 2023
Figure 77: Middle East and Africa: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Global: Macular Degeneration Treatment Industry: SWOT Analysis
Figure 79: Global: Macular Degeneration Treatment Industry: Value Chain Analysis
Figure 80: Global: Macular Degeneration Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Macular Degeneration Treatment Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Macular Degeneration Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Macular Degeneration Treatment Market Forecast: Breakup by Stage of Disease (in Million US$), 2024-2032
Table 4: Global: Macular Degeneration Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 5: Global: Macular Degeneration Treatment Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Macular Degeneration Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Macular Degeneration Treatment Market: Competitive Structure
Table 8: Global: Macular Degeneration Treatment Market: Key Players

Macular Degeneration Treatment Market Report by Type (Dry Age-related Macular Degeneration, Wet Age-related Macular Degeneration), Stage of Disease (Early Stage, Intermediate Stage, Late Stage), Route of Administration (Intravenous Route, Intravitreal Route), End User (Hospitals, Ambulatory Surgical Center, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More